Keywords: ER; estrogen receptor; HER2; human epidermal growth factor receptor 2; MP; MammaPrint; MSP; multigene signature panel; ODX; Oncotype DX;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Genomic medicine; Guideline-concordance; Oncotype DX; Risk stratification; Veterans;
Keywords: Breast cancer; Gene expression test; Oncotype DX; Budget impact analysis; Germany; Health economics;
Keywords: Breast cancer; Recurrence; Chemotherapy; Oncotype DX; Gene assay;
Disparities in compliance with the Oncotype DX breast cancer test in the United States: A National Cancer Data Base assessment
Keywords: Oncotype DX; Breast cancer; Compliance; Disparities;
Impact of the 12-Gene Colon Cancer Assay on Clinical Decision Making for Adjuvant Therapy in Stage II Colon Cancer Patients
Keywords: adjuvant chemotherapy; colon cancer; decision impact; 12-gene colon cancer assay; Oncotype DX; Recurrence Score;
Oncotype DX® colon cancer assay for prediction of recurrence risk in patients with stage II and III colon cancer: A review of the evidence
Keywords: Colon cancer; Oncotype DX; 12-Gene assay; Genomic assay; Adjuvant chemotherapy; Multigene assay; Colon cancer recurrence risk; Colon cancer treatment; Oxaliplatin
Original StudyA Validated Model for Identifying Patients Unlikely to Benefit From the 21-Gene Recurrence Score Assay
Keywords: Classification model; Grade; Oncotype DX; Predictive value of tests; Risk assessment; TAILORx; Tumor markers;
Menopausal status does not predict Oncotype DX recurrence score
Keywords: Premenopausal; Breast cancer; Recurrence; Adjuvant therapy; Oncotype DX
The impact of Oncotype DX testing on breast cancer management and chemotherapy prescribing patterns in a tertiary referral centre
Keywords: Breast cancer; Oncotype DX; Oncotype; Genomic profiling; Genomic assay; Recurrence score; Adjuvant chemotherapy; Chemotherapy; Individualised therapy;
Prediction of Oncotype DX and TAILORx risk categories using histopathological and immunohistochemical markers by classification and regression tree (CART) analysis
Keywords: Oncotype DX; TAILORx; Breast cancer; Immunohistochemistry; PR; Ki67;
Interest and attitudes of patients, cancer physicians, medical students and cancer researchers towards a spectrum of genetic tests relevant to breast cancer patients
Keywords: Breast cancer; BRCA1/2; CYP2D6; Genetic testing; Oncotype DX
The value of comparative effectiveness research: Projected return on investment of the RxPONDER trial (SWOG S1007)
Keywords: Value of research; Comparative effectiveness research; Oncotype Dx; Breast cancer; Clinical trial